105 related articles for article (PubMed ID: 15321735)
1. Serotonin aggravates exercise-induced cardiac ischemia in the dog: effect of serotonin receptor antagonists.
Guilbert F; Lainée P; Dubreuil B; McCort G; O'Connor SE; Janiak P; Herbert JM
Eur J Pharmacol; 2004 Aug; 497(1):55-63. PubMed ID: 15321735
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist.
Berry CN; Lorrain J; Lochot S; Delahaye M; Lalé A; Savi P; Lechaire I; Ferrari P; Bernat A; Schaeffer P; Janiak P; Duval N; Grosset A; Herbert JM; O'Connor SE
Thromb Haemost; 2001 Mar; 85(3):521-8. PubMed ID: 11307825
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist.
O'Connor SE; Grosset A; La Rochelle CD; Gautier E; Bidouard JP; Robineau P; Caille D; Janiak P
Eur J Pharmacol; 2001 Mar; 414(2-3):259-69. PubMed ID: 11239927
[TBL] [Abstract][Full Text] [Related]
4. SL65.0472 blocks 5-hydroxytryptamine-induced vasoconstriction in a dog hindlimb ischemia model.
Barbe F; Gautier E; Bidouard JP; Grosset A; O'Connor SE; Janiak P
Eur J Pharmacol; 2003 Aug; 474(1):117-20. PubMed ID: 12909202
[TBL] [Abstract][Full Text] [Related]
5. The prototype serotonin 5-HT 1B/1D agonist sumatriptan increases the severity of myocardial ischemia during atrial pacing in dogs with coronary artery stenosis.
Lynch JJ; Stump GL; Kane SA; Regan CP
J Cardiovasc Pharmacol; 2009 Jun; 53(6):474-9. PubMed ID: 19430309
[TBL] [Abstract][Full Text] [Related]
6. Selective blockade of serotonin 5-HT2A receptor increases coronary blood flow via augmented cardiac nitric oxide release through 5-HT1B receptor in hypoperfused canine hearts.
Fujita M; Minamino T; Sanada S; Asanuma H; Hirata A; Ogita H; Okada K; Tsukamoto O; Takashima S; Tomoike H; Node K; Hori M; Kitakaze M
J Mol Cell Cardiol; 2004 Dec; 37(6):1219-23. PubMed ID: 15572052
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin gene-related peptide receptor antagonism does not affect the severity of myocardial ischemia during atrial pacing in dogs with coronary artery stenosis.
Regan CP; Stump GL; Kane SA; Lynch JJ
J Pharmacol Exp Ther; 2009 Feb; 328(2):571-8. PubMed ID: 18997059
[TBL] [Abstract][Full Text] [Related]
8. Modulation of vasoactivity and platelet aggregation by selective 5-HT receptor antagonism in humans.
Moerland M; Kemme M; Dijkmans A; Bergougnan L; Burggraaf J
J Cardiovasc Pharmacol; 2011 Dec; 58(6):575-80. PubMed ID: 21822145
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
[TBL] [Abstract][Full Text] [Related]
10. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
11. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
12. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
[TBL] [Abstract][Full Text] [Related]
13. Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction.
Galzin AM; Delahaye M; Hoornaert C; McCort G; O'Connor SE
Eur J Pharmacol; 2000 Sep; 404(3):361-8. PubMed ID: 10996601
[TBL] [Abstract][Full Text] [Related]
14. Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.
Valentin JP; Vieu S; Bertolino F; Fauré P; John GW
J Pharmacol Exp Ther; 1997 Feb; 280(2):761-9. PubMed ID: 9023289
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of ketanserin in closed-chest anesthetized dogs.
van de Water A; Wouters L; Xhonneux R; Reneman S
Arch Int Pharmacodyn Ther; 1985 Jun; 275(2):267-78. PubMed ID: 3161481
[TBL] [Abstract][Full Text] [Related]
16. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544
[TBL] [Abstract][Full Text] [Related]
17. Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning.
Monnet X; Ghaleh B; Colin P; de Curzon OP; Giudicelli JF; Berdeaux A
J Pharmacol Exp Ther; 2001 Dec; 299(3):1133-9. PubMed ID: 11714904
[TBL] [Abstract][Full Text] [Related]
18. Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction.
Lau DH; Thompson CS; Bellringer JF; Thomas PJ; Mumtaz FH; Morgan RJ; Mikhailidis DP
J Androl; 2006; 27(5):679-85. PubMed ID: 16728720
[TBL] [Abstract][Full Text] [Related]
19. Serotonin receptor blockade improves distal perfusion after lower limb ischemia in the fatty Zucker rat.
Janiak P; Lainée P; Grataloup Y; Luyt CE; Bidouard JP; Michel JB; O'Connor SE; Herbert JM
Cardiovasc Res; 2002 Nov; 56(2):293-302. PubMed ID: 12393100
[TBL] [Abstract][Full Text] [Related]
20. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
